Skip to content

Clinical trials

Phase 1/2 Retinal Vein Occlusion trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Vein Occlusion Phase: Phase 1/2 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20101
20113
20123
20131
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)2
Peter A Campochiaro, MD2
Allergan1
California Retina Consultants1
Centro de Pesquisa Rubens Siqueira1
EyeBiotech Ltd.1
Hanscom, Thomas, M.D.1
Ohr Pharmaceutical Inc.1
Ophthalmic Consultants of Boston1
Sanwa Kagaku Kenkyusho Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Vein Occlusion14
Macular Edema7
Eye Diseases2
Macular Degeneration2
Carotid Stenosis1
Glaucoma1
Glaucoma, Neovascular1
Retinal Diseases1

Trials

Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.